Founded in 2005, Amega Biotech is an umbrella organization supporting a number of biotechnology companies based in Argentina. With the acquisition of several companies and the building of a new plant in Buenos Aires, Argentina, Amega Biotech entered the biotechnology industry with a new vision. The company is dedicated to the development, manufacturing and commercialization of biopharmaceuticals, including high-quality biogenerics and novel drug delivery systems, as well as to the innovation in oncology and infectious diseases treatments. The company´s fill-finishing quality is guaranteed through a careful selection of different cGMP compliant alliances, while seeking new partnerships to assure the full process success. Apart from emphasizing competitiveness and the importance of "time to market", the company´s structure also allows whole process control, from the raw material (API) to the finished product. This new vision enables the company´s access to world markets.